Glucuronolactone tablets
Function and Efficacy
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.
Ingredients
Each tablet of this product contains 100 mg of the main ingredient glucuronolactone. The auxiliary materials are fillers: starch, dextrin; adhesive: starch slurry; lubricant: magnesium stearate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| D-GlucuroneIngredients |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. More |
32449-92-6 | 6 | |
| StarchExcipients |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. More |
9005-25-8 | 78 | |
| DextrinExcipients |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. More |
9004-53-9 | 50 | |
| Magnesium stearateExcipients |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. More |
557-04-0 | 61 |
Appearance
This product is white tablets.
Indication
Used as adjuvant treatment for acute and chronic hepatitis.
Usage and Dosage
Oral administration. Adults: 1-2 tablets each time, 3 times a day. Children under 5 years old: half a tablet each time, and children over 5 years old: 1 tablet each time, 3 times a day.
Adverse Reactions
Occasionally, facial flushing and mild gastrointestinal discomfort may occur, which will disappear after reducing the dosage or stopping the drug.
Precautions
Not yet clear
Special Population Medication
Precautions for children: Children must use under adult supervision. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
If you are taking other medicines, please consult your physician or pharmacist before using this product.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
0.1g
Validity Period
Year 2
Manufacturer
Jiangsu Tasly DIYI Pharmaceutical Co., Ltd.
-
Founded in:
1999-03-24 -
Address:
No. 168, Chaoyang West Road, Qingpu Industrial Park, Huai'an City -
Tax NO.:
91320800139432975C -
Registered Funds:
66.86 million yuan -
Website:
-
Email: